:
Live Cell encapsulation is a process in which living cells are encapsulated in selectively permeable polymeric materials (membranes/beads), making them a potential treatment for diseases like Parkinson's disease, haemophilia, lysosomal storage disorder (LSD), cancer, and diabetes..
MARKET SCOPE
The "Live cell encapsulation market to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of live cell encapsulation market with detailed market segmentation by of Industry and Technology. The live cell encapsulation market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in live cell encapsulation market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
-n the basis of manufacturing technique, the market is segmented into Simple Dripping, Electrostatic Dripping, Coaxial Airflow, Liquid-Jet Break-Up, Vibrating-Jet Technique, Jet Cutting and Rotating Disk Atomization.
-n the basis of polymer type the market is segmented into Aginate, Hema-Mma, Chitosan, Siliceous Encapsulates, Cellulose Sulfate, PAN-PVC, Others.
-n the basis of application the market is segmented into Drug Delivery, Regenerative Medicine, Cell Transplantation, Probiotics and Research
MARKET DYNAMICS
Drivers:
-Increased public-private investments to support product development, increased research to establish the clinical efficacy of cell encapsulation technologies, and rising public awareness about the clinical role of encapsulated cells in disease management are all driving growth in the live cell encapsulation market.
Restraints
During the forecast period, the market is expected to be hampered by a lack of high-quality raw materials and a significant adoption of alternative therapies.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the live cell encapsulation market based on various segments. It also provides market size and forecast estimates from year 2021 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The live cell encapsulation market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting live cell encapsulation market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the live cell encapsulation market in these regions.
IMPACT OF COVID-19 ON LIVE CELL ENCAPSULATION MARKET:
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. The global impacts of the COVID-19 are already starting to be felt, and will significantly affect the live cell encapsulation market in 2020.Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
MARKET PLAYERS
The report covers key developments in the live cell encapsulation market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from live cell encapsulation market are anticipated to have lucrative growth opportunities in the future with the rising demand for live cell encapsulation market in the global market. Below mentioned is the list of few companies engaged in the live cell encapsulation market.
The report also includes the profiles of key players in live cell encapsulation market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
Merck
-MIKROCAPS
-Encapsys, LLC
-Blacktrace
-Living Cell Technologies Ltd.
-Sernova, Corp.
-Defymed
-BioTime, Inc
-Atelerix Ltd
-Sigilon Therapeutics, Inc
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.